Michael Piershbacher Net Worth

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Michael Piershbacher IART stock SEC Form 4 insiders trading

Michael has made over 1 trades of the Integra Lifesciences Corp stock since 2004, according to the Form 4 filled with the SEC. Most recently Michael sold 2,693 units of IART stock worth $82,190 on 3 March 2004.

The largest trade Michael's ever made was selling 2,693 units of Integra Lifesciences Corp stock on 3 March 2004 worth over $82,190. On average, Michael trades about 673 units every 0 days since 2003.

You can see the complete history of Michael Piershbacher stock trades at the bottom of the page.

What's Michael Piershbacher's mailing address?

Michael's mailing address filed with the SEC is , , , , .

Insiders trading at Integra Lifesciences Corp

Over the last 22 years, insiders at Integra Lifesciences Corp have traded over $397,927,161 worth of Integra Lifesciences Corp stock and bought 132,879 units worth $4,504,827 . The most active insiders traders include Neal Moszkowski, Stuart Essig y George Soros. On average, Integra Lifesciences Corp executives and independent directors trade stock every 19 days with the average trade being worth of $668,131. The most recent stock trade was executed by Jeffrey Mosebrook on 19 August 2024, trading 1,191 units of IART stock currently worth $25,702.

What does Integra Lifesciences Corp do?

integra lifesciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. in the united states, integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. founded in 1989 integra is headquartered in plainsboro, new jersey and has over 3,500 employees worldwide. integra's common stock is li

Complete history of Michael Piershbacher stock trades at Integra Lifesciences Corp

Integra Lifesciences Corp executives and stock owners

Integra Lifesciences Corp executives and other stock owners filed with the SEC include:

• Peter Arduini,
  President, Chief Executive Officer, Director
• Glenn Coleman,
  Chief Operating Officer, Executive Vice President
• Carrie Anderson,
  Chief Financial Officer, Executive Vice President
• Eric Schwartz,
  Executive Vice President, Chief Legal Officer, Secretary
• Robert Davis,
  Executive Vice President, President - Orthopedics and Tissue Technologies
• Glenn G. Coleman,
  Exec. VP & COO
• Carrie L. Anderson,
  Exec. VP, CFO & Treasurer
• Robert T. Davis Jr.,
  Exec. VP and Pres of Orthopedics & Tissue Technologies
• Stuart Essig,
  Independent Chairman of the Board
• Rhonda Ballintyn,
  Independent Director
• Barbara Hill,
  Independent Presiding Director
• Christian Schade,
  Independent Director
• Donald Morel,
  Independent Director
• Lloyd Howell,
  Independent Director
• Keith Bradley,
  Independent Director
• Raymond Murphy,
  Independent Director
• Michael Beaulieu,
  IR Contact Officer
• Jeffrey Mosebrook,
  Senior Vice President, Principal Accounting Officer
• Michael McBreen,
  Executive Vice President and President - Codman Specialty Surgical
• Lisa Evoli,
  Executive Vice President, Chief Human Resources Officer
• Eric Ian Schwartz,
  Exec. VP, Chief Legal Officer & Sec.
• William Compton,
  Chief Information Officer & Sr. VP
• Dr. Kenneth E. Burhop Ph.D.,
  Corp. VP & Chief Scientific Officer
• Jeffrey Mosebrook,
  Sr. VP, Principal Accounting Officer & Corp. Controller
• Dr. Richard E. Caruso,
  Founder and Chairman Emeritus
• Jan De Witte,
  Pres, CEO & Director
• James M Sullivan,
  Director
• John Mooradian,
  Corp VP, Global Ops & Supp Chn
• Judith Ogrady,
  CorpVP,Global Reg.Affairs
• Kenneth Burhop,
  CORPVP,CHIEFSCIENTIFIC OFFICER
• Mark A Augusti,
  CVP,PRES-ORTHO & TISSUE TECH
• Richard D. Gorelick,
  Corp VP, Gen Counsel & Sec
• Harvinder Singh,
  EVP & PRESIDENT, INTERNATIONAL
• Chantal Veillon Berteloot,
  EVP & CHRO
• Richard E Caruso,
  10% owner
• Witte Jan De,
  President & CEO
• Joseph Vinhais,
  Corp VP,Quality&Transformation
• George Soros,
  10% owner
• David B Holtz,
  Sr. VP, Finance
• David C Auth,
  Director
• Don R Nociolo,
  Senior V.P., Operations
• Michael Piershbacher,
  Senior VP, Research & Dev.
• Maureen B Bellantoni,
  Exec V.P./CFO
• Neal Moszkowski,
  Director
• Anne Vanlent,
  Director
• Thomas J Jr Baltimore,
  Director
• Daniel L. Reuvers,
  CVP,PRES - CODMAN SPC SURGICAL
• Deborah A Leonetti,
  Senior VP, Marketing
• Padma Thiruvengadam,
  Corp VP, Chief HR Officer
• Robert D Paltridge,
  Sr. VP, Global Sales
• Gerard S Carlozzi,
  Exec. V.P., COO
• Brian Larkin,
  Corp VP, Pres.Gbl Spine &Ortho
• John B Iii Henneman,
  Exec. V.P., CAO, & Secretary
• Jerry E Corbin,
  VP & Corporate Controller
• St Partnership, L.P. Tru,
  10% owner
• Jeffrey A Graves,
  Director
• Renee Wonlai Lo,
  Director
• Lea Daniels Knight,
  EVP & CHIEF FINANCIAL OFFICER